Meet our Portfolio Companies
Antiverse
Combining AI and wet lab biology to design de novo antibodies for challenging GPCR targets implicated in cancer and immune diseases.
Arrepath
Anti-infective discovery platform coupling cell imaging with machine learning analysis to identify new drug candidates and new mechanisms of action.
Dyania Health
Natural language processing for complex, unstructured medical data to accelerate patient matching to clinical trials and enable real world data research.
Encora
Wearable device delivering AI-informed vibrational neurostimulation to sense & reduce tremors in real time for Parkinson’s & Essential Tremor patients.
Javelin Biotech
Microphysiological systems combining organs-on-chips, multi-omic analysis, and AI-driven modeling to accelerate drug discovery and development.
Odaia Intelligence
AI-driven SaaS platform creating more targeted, impactful engagement between healthcare providers and pharma sales teams.
Olaris Therapeutics
Precision diagnostics platform combining metabolomics with machine learning to predict biomarkers response that help optimize treatment outcomes.
Path.AI
AI-driven pathology analysis enabling research and assisting pathologists in making rapid and accurate diagnoses for every patient, every time.
Persist.AI
ML-powered platform that predicts extended-release formulations for any drug, enabling generics manufacturers to get XR formulations to market.
Zeta Surgical
Computer vision for bedside image-based navigation in minimally invasive surgery, enabling new treatments in neurological surgery and beyond.